Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1790-91-6

Post Buying Request

1790-91-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1790-91-6 Usage

Description

2,3-Dichloro-6,7-dimethoxyquinoxaline is a complex organic compound that belongs to the class of quinoxalines, which are heterocyclic compounds containing carbon, nitrogen, hydrogen, chlorine, and oxygen atoms in their main ring structure. 2,3-DICHLORO-6,7-DIMETHOXYQUINOXALINE is known for its versatility and pharmacological potential, making it a valuable entity in the field of medicinal chemistry. The presence of halogens and methoxy groups endows this compound with unique biological activities. Due to its chemical nature, specific safety and handling precautions are necessary to ensure safe usage and mitigate health hazards.

Uses

Used in Medicinal Chemistry:
2,3-Dichloro-6,7-dimethoxyquinoxaline is used as a key intermediate in the synthesis of various pharmaceutical compounds for its potential therapeutic applications. 2,3-DICHLORO-6,7-DIMETHOXYQUINOXALINE's structural features, including the presence of halogens and methoxy groups, contribute to its biological activity, making it a promising candidate for drug development.
Used in Research and Development:
In the scientific community, 2,3-Dichloro-6,7-dimethoxyquinoxaline is utilized as a research tool to study the effects of its structural components on biological systems. This helps in understanding the compound's interactions with biological targets and its potential applications in the development of new therapeutic agents.
Used in Drug Design and Optimization:
2,3-Dichloro-6,7-dimethoxyquinoxaline serves as a building block in the design and optimization of new drugs. Its unique structural features allow for the creation of novel chemical entities with improved pharmacological properties, such as increased potency, selectivity, and reduced side effects.
Used in Chemical Synthesis:
2,3-DICHLORO-6,7-DIMETHOXYQUINOXALINE is also used as a reagent in various chemical synthesis processes, where its versatile structure can be further modified to produce a range of different chemical products with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 1790-91-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,9 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1790-91:
(6*1)+(5*7)+(4*9)+(3*0)+(2*9)+(1*1)=96
96 % 10 = 6
So 1790-91-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H8Cl2N2O2/c1-15-7-3-5-6(4-8(7)16-2)14-10(12)9(11)13-5/h3-4H,1-2H3

1790-91-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-DICHLORO-6,7-DIMETHOXYQUINOXALINE

1.2 Other means of identification

Product number -
Other names 2,3-dichloro-6,7-dimethoxy-quinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1790-91-6 SDS

1790-91-6Downstream Products

1790-91-6Relevant articles and documents

Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient

-

Paragraph 0976-0979, (2020/02/20)

Provided are a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative, a method for preparing the same, and a pharmaceutical composition for preventing or treating bromodomain extra-terminal (BET) protein-related diseases including cancer and autoimmune disea

Imidazoquinoxaline protein tyrosine kinase inhibitors

-

, (2008/06/13)

Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1790-91-6